Emplicure AB/News/BioStock: Emplicure's Chairman of the Board comments on the change of CEO

BioStock: Emplicure's Chairman of the Board comments on the change of CEO

07 October 2022 - 08:47

Emplicure enters autumn with a new CEO and an approved application for a clinical pharmacokinetic study. BioStock talked to Chairman of the Board Gisela Sitbon about the company's eventful autumn and the reasoning behind the change of CEO.

Read the full article about Emplicure at biostock.se:

https://www.biostock.se/en/2022/10/emplicures-chairman-of-the-board-comments-on-the-change-of-ceo

This is a press release from BioStock – Connecting Innovation & Capital. https://www.biostock.se/en

Provided by: Cision

Emplicure AB

Emplicure is a pharmaceutical company that develops new innovative drugs based on the combination of already approved active substances and advanced materials science in bioceramics. The product portfolio initially focuses on drugs for chronic pain and with addictive properties....

Learn more about company

Related news

27.09.2023

Redwood Pharma AB

Redwood Pharma AB meddelar sista dag för handel med BTU och första dag för handel med teckningsoptioner av serie TO 5

EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, I USA, AUSTRALIEN, JAPAN, KANADA, NYA ZEELAND, SYDAFRIKA, HONGKONG, SCHWEIZ, SINGAPORE, SYDKOREA, RYSSLAND, BELARUS ELLER I NÅGON ANNAN JURISDIKTION DÄR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING AV DETTA...

27.09.2023

Integrum AB

Årsstämmokommuniké – Integrum AB

Resultat- och balansräkningen samt koncernresultat- och koncernbalansräkningen för räkenskapsåret 1 maj 2022–30 april 2023 fastställdes. I enlighet med styrelsens förslag beslutades att inte lämna någon utdelning utan att fritt eget kapital, 151 1...

27.09.2023

ExpreS2ion Biotech Holding AB

ExpreS2ion announces changes to leadership team

Hørsholm, Denmark, 27 September 2023 - ExpreS2ion Biotech Holding AB (“ExpreS2ion” or the “Company”), a pioneer in the development of innovative vaccines for a healthier world, today announced that Dr. Mattis Ranthe, Chief Medical Officer, and Dr. Mette Thorn, Senior Vice President of Preclinical De...

27.09.2023

Pharmacolog i Uppsala AB

Pharmacolog appoints finance manager

Sofia ends the assignment as interim CFO at Pharmacolog and Liselotte Söder returns as interim finance manager. Liselotte, who is an authorized accountant and certified controller with broad experience of financial management in listed companies, brings previous experience from Pharmacolog and will...